{"id":"https://openalex.org/W1994589145","doi":"https://doi.org/10.1300/j069v21n02_01","title":"Bupropion Treatment for Cocaine Abuse and Adult Attention-Deficit/Hyperactivity Disorder","display_name":"Bupropion Treatment for Cocaine Abuse and Adult Attention-Deficit/Hyperactivity Disorder","publication_year":2002,"publication_date":"2002-02-27","ids":{"openalex":"https://openalex.org/W1994589145","doi":"https://doi.org/10.1300/j069v21n02_01","mag":"1994589145","pmid":"https://pubmed.ncbi.nlm.nih.gov/11916368"},"language":"en","primary_location":{"id":"doi:10.1300/j069v21n02_01","doi":"https://doi.org/10.1300/j069v21n02_01","is_oa":false,"landing_page_url":"https://doi.org/10.1300/j069v21n02_01","pdf_url":null,"source":{"id":"https://openalex.org/S93508928","display_name":"Journal of Addictive Diseases","issn_l":"1055-0887","issn":["1055-0887","1545-0848"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Addictive Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083379140","display_name":"FRANCES RUDNICK LEVIN","orcid":"https://orcid.org/0000-0003-4209-1329","observed_orcids":["https://orcid.org/0000-0003-4209-1329"]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frances R. Levin","raw_affiliation_strings":["Department of Psychiatry, Columbia University/New York State Psychiatric Institute, New York 10032, USA. fr12@columbia.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University/New York State Psychiatric Institute, New York 10032, USA. fr12@columbia.edu","institution_ids":["https://openalex.org/I4388891851","https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056961169","display_name":"Suzette M. Evans","orcid":"https://orcid.org/0000-0002-5397-2853","observed_orcids":["https://orcid.org/0000-0002-5397-2853"]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzette M. Evans","raw_affiliation_strings":["Department of Psychiatry, Columbia University/New York State Psychiatric Institute, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University/New York State Psychiatric Institute, New York, USA","institution_ids":["https://openalex.org/I4388891851","https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087454229","display_name":"David M. McDowell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. McDowell","raw_affiliation_strings":["Department of Psychiatry, Columbia University/New York State Psychiatric Institute, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University/New York State Psychiatric Institute, New York, USA","institution_ids":["https://openalex.org/I4388891851","https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Daniel J. Brooks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. Brooks","raw_affiliation_strings":["Department of Psychiatry, Columbia University/New York State Psychiatric Institute, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University/New York State Psychiatric Institute, New York, USA","institution_ids":["https://openalex.org/I4388891851","https://openalex.org/I78577930"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073707428","display_name":"Edward V. Nunes","orcid":"https://orcid.org/0000-0002-2055-3425","observed_orcids":["https://orcid.org/0000-0002-2055-3425"]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Nunes","raw_affiliation_strings":["Department of Psychiatry, Columbia University/New York State Psychiatric Institute, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University/New York State Psychiatric Institute, New York, USA","institution_ids":["https://openalex.org/I4388891851","https://openalex.org/I78577930"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.0124,"has_fulltext":false,"cited_by_count":102,"citation_normalized_percentile":{"value":0.93513392,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"21","issue":"2","first_page":"1","last_page":"16"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.014499999582767487,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bupropion","display_name":"bupropion","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":0.9900000095367432},{"id":"https://openalex.org/keywords/adult-adhd","display_name":"adult ADHD","score":0.9549999833106995},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.9419999718666077},{"id":"https://openalex.org/keywords/cocaine-craving","display_name":"cocaine craving","score":0.8259999752044678},{"id":"https://openalex.org/keywords/impulsivity","display_name":"impulsivity","score":0.6759999990463257},{"id":"https://openalex.org/keywords/hyperactivity","display_name":"hyperactivity","score":0.6779999732971191},{"id":"https://openalex.org/keywords/addiction-treatment","display_name":"addiction treatment","score":0.4699999988079071},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.8203147649765015},{"id":"https://openalex.org/C2779796075","wikidata":"https://www.wikidata.org/wiki/Q3743188","display_name":"Cocaine dependence","level":3,"score":0.7277727723121643},{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.7228983640670776},{"id":"https://openalex.org/C2780319597","wikidata":"https://www.wikidata.org/wiki/Q1549918","display_name":"Impulsivity","level":2,"score":0.6167199015617371},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5749439597129822},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5619403123855591},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.549556314945221},{"id":"https://openalex.org/C2779541405","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Craving","level":3,"score":0.5489618182182312},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5113177299499512},{"id":"https://openalex.org/C3020194580","wikidata":"https://www.wikidata.org/wiki/Q41576","display_name":"Cocaine use","level":2,"score":0.4574434459209442},{"id":"https://openalex.org/C2910455596","wikidata":"https://www.wikidata.org/wiki/Q3743188","display_name":"Cocaine abuse","level":2,"score":0.44914698600769043},{"id":"https://openalex.org/C2781089641","wikidata":"https://www.wikidata.org/wiki/Q7310684","display_name":"Relapse prevention","level":2,"score":0.43577444553375244},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.42569804191589355},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.33338475227355957},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.26418668031692505},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.06993368268013},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016037","descriptor_name":"Single-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1300/j069v21n02_01","doi":"https://doi.org/10.1300/j069v21n02_01","is_oa":false,"landing_page_url":"https://doi.org/10.1300/j069v21n02_01","pdf_url":null,"source":{"id":"https://openalex.org/S93508928","display_name":"Journal of Addictive Diseases","issn_l":"1055-0887","issn":["1055-0887","1545-0848"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Addictive Diseases","raw_type":"journal-article"},{"id":"pmid:11916368","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11916368","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of addictive diseases","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G2759942248","display_name":"TREATMENT OF COCAINE ABUSE AND PSYCHIATRIC COMORBIDITY","funder_award_id":"K20DA000214","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5666870107","display_name":"Novel Medication Approaches for Substance Abuse","funder_award_id":"P50DA009236","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W81573692","https://openalex.org/W1209980950","https://openalex.org/W1506870724","https://openalex.org/W1682399119","https://openalex.org/W1684863429","https://openalex.org/W1709379088","https://openalex.org/W1751180885","https://openalex.org/W1782783388","https://openalex.org/W1964767493","https://openalex.org/W1974991760","https://openalex.org/W1976367650","https://openalex.org/W1989428478","https://openalex.org/W1995973822","https://openalex.org/W2001448102","https://openalex.org/W2005075493","https://openalex.org/W2017312379","https://openalex.org/W2024374498","https://openalex.org/W2025702178","https://openalex.org/W2035317930","https://openalex.org/W2041100912","https://openalex.org/W2046496684","https://openalex.org/W2049710132","https://openalex.org/W2050266641","https://openalex.org/W2055941668","https://openalex.org/W2059861818","https://openalex.org/W2061059960","https://openalex.org/W2071280486","https://openalex.org/W2074460102","https://openalex.org/W2080813865","https://openalex.org/W2090481799","https://openalex.org/W2108483316","https://openalex.org/W2112151032","https://openalex.org/W2143384791","https://openalex.org/W2144961582","https://openalex.org/W2148462481","https://openalex.org/W2155225295","https://openalex.org/W2312357066","https://openalex.org/W2994532047","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2017312379","https://openalex.org/W2050480092","https://openalex.org/W146333002","https://openalex.org/W2072946923","https://openalex.org/W2080586308","https://openalex.org/W2035487281","https://openalex.org/W2059273878","https://openalex.org/W2005075493","https://openalex.org/W1966490087","https://openalex.org/W2151045040"],"abstract_inverted_index":{"There":[0],"are":[1],"few":[2],"published":[3,88],"studies":[4],"assessing":[5],"the":[6],"efficacy":[7],"of":[8,41,45,109,113],"pharmacologic":[9],"treatments":[10],"for":[11,28,97,153],"attention-deficit":[12],"hyperactivity":[13,70],"disorder":[14],"(ADHD)":[15],"among":[16],"substance":[17],"abusers":[18,155],"seeking":[19],"treatment.":[20],"Eleven":[21],"patients":[22,49,91],"who":[23,92],"met":[24,93],"DSM-IV":[25],"diagnostic":[26,95],"criteria":[27,96],"cocaine":[29,74,76,79,101,154],"dependence":[30,102],"and":[31,59,71,78,100,124],"adult":[32,98,157],"ADHD":[33,99],"were":[34,61,103,121],"entered":[35,104],"into":[36,105],"a":[37,86,106,160,169],"12-week":[38,107],"single-blind":[39],"trial":[40,108,172],"divided":[42,110],"daily":[43,111],"doses":[44,112],"bupropion":[46],"(BPR).":[47],"All":[48],"received":[50],"weekly":[51],"individual":[52],"standardized":[53],"relapse":[54,150],"prevention":[55,151],"therapy.":[56],"Treatment":[57],"compliance":[58],"retention":[60],"good.":[62],"Patients":[63],"reported":[64],"significant":[65],"reductions":[66],"in":[67,168],"attention":[68],"difficulties,":[69],"impulsivity.":[72],"Self-reported":[73],"use,":[75],"craving,":[77],"positive":[80],"toxicologies,":[81],"also":[82],"decreased":[83],"significantly.":[84],"In":[85],"previously":[87,130],"trial,":[89],"12":[90],"similar":[94,122],"sustained-release":[114,145],"methylphenidate":[115],"(MPH).":[116],"Improvements":[117],"observed":[118,131],"on":[119],"BPR":[120,139,165],"to,":[123],"did":[125],"not":[126],"differ":[127],"from":[128],"those":[129],"with":[132,149,156],"MPH.":[133],"These":[134],"preliminary":[135],"data":[136],"suggest":[137],"that":[138],"may":[140],"be":[141],"as":[142,144],"effective":[143],"MPH,":[146],"when":[147],"combined":[148],"therapy,":[152],"ADHD.":[158],"However,":[159],"future":[161],"study":[162],"directly":[163],"comparing":[164],"to":[166],"MPH":[167],"double-blind":[170],"placebo-controlled":[171],"is":[173],"needed.":[174]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}